Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2016

01-06-2016 | Preclinical study

Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation

Authors: Gabriela Szalayova, Aleksandra Ogrodnik, Brianna Spencer, Jacqueline Wade, Janice Bunn, Abiy Ambaye, Ted James, Mercedes Rincon

Published in: Breast Cancer Research and Treatment | Issue 3/2016

Login to get access

Abstract

Chronic inflammation is known to facilitate cancer progression and metastasis. Less is known about the effect of acute inflammation within the tumor microenvironment, resulting from standard invasive procedures. Recent studies in mouse models have shown that the acute inflammatory response triggered by a biopsy in mammary cancer increases the frequency of distal metastases. Although tumor biopsies are part of the standard clinical practice in breast cancer diagnosis, no studies have reported their effect on inflammatory response. The objective of this study is to (1) determine whether core needle biopsies in breast cancer patients trigger an inflammatory response, (2) characterize the type of inflammatory response present, and (3) evaluate the potential effect of any acute inflammatory response on residual tumor cells. The biopsy wound site was identified in the primary tumor resection tissue samples from breast cancer patients. The inflammatory response in areas adjacent (i.e., immediately around previous biopsy site) and distant to the wound biopsy was investigated by histology and immunohistochemistry analysis. Proliferation of tumor cells was also assayed. We demonstrate that diagnostic core needle biopsies trigger a selective recruitment of inflammatory cells at the site of the biopsy, and they persist for extended periods of time. While macrophages were part of the inflammatory response, an unexpected accumulation of eosinophils at the edge of the biopsy wound was also identified. Importantly, we show that biopsy causes an increase in the proliferation rate of tumor cells located in the area adjacent to the biopsy wound. Diagnostic core needle biopsies in breast cancer patients do induce a unique acute inflammatory response within the tumor microenvironment and have an effect on the surrounding tumor cells. Therefore, biopsy-induced inflammation could have an impact on residual tumor cell progression and/or metastasis in human breast cancer. These findings may carry relevance in the clinical management of breast cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, et al (2015) SEER Cancer Statistics Review, 1975–2012, National Cancer Institute. Bethesda. http://www.seercancergov/csr/1975_2012/ based on November 2014 SEER data submission, posted to the SEER web site, April 2015 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, et al (2015) SEER Cancer Statistics Review, 1975–2012, National Cancer Institute. Bethesda. http://​www.​seercancergov/​csr/​1975_​2012/​ based on November 2014 SEER data submission, posted to the SEER web site, April 2015
3.
go back to reference Shalapour S, Karin M (2015) Immunity, inflammation, and cancer: an eternal fight between good and evil. J Clin Invest 125:3347–3355CrossRefPubMed Shalapour S, Karin M (2015) Immunity, inflammation, and cancer: an eternal fight between good and evil. J Clin Invest 125:3347–3355CrossRefPubMed
5.
go back to reference Bhatelia K, Singh K, Singh R (2014) TLRs: linking inflammation and breast cancer. Cell Signal 26:2350–2357CrossRefPubMed Bhatelia K, Singh K, Singh R (2014) TLRs: linking inflammation and breast cancer. Cell Signal 26:2350–2357CrossRefPubMed
6.
go back to reference Demaria S, Pikarsky E, Karin M, Coussens LM, Chen YC, El-Omar EM, Trinchieri G, Dubinett SM, Mao JT, Szabo E et al (2010) Cancer and inflammation: promise for biologic therapy. J Immunother 33:335–351CrossRefPubMedPubMedCentral Demaria S, Pikarsky E, Karin M, Coussens LM, Chen YC, El-Omar EM, Trinchieri G, Dubinett SM, Mao JT, Szabo E et al (2010) Cancer and inflammation: promise for biologic therapy. J Immunother 33:335–351CrossRefPubMedPubMedCentral
7.
go back to reference Grivennikov SI, Karin M (2011) Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 70(Suppl 1):i104–i108CrossRefPubMed Grivennikov SI, Karin M (2011) Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 70(Suppl 1):i104–i108CrossRefPubMed
8.
go back to reference Multhoff G, Molls M, Radons J (2011) Chronic inflammation in cancer development. Front Immunol 2:98PubMed Multhoff G, Molls M, Radons J (2011) Chronic inflammation in cancer development. Front Immunol 2:98PubMed
10.
go back to reference Szalayova G, James TA, Rincon M (2015) A framework for the role of acute inflammation in tumor progression. Breast Cancer Res Treat 151:235–238CrossRefPubMed Szalayova G, James TA, Rincon M (2015) A framework for the role of acute inflammation in tumor progression. Breast Cancer Res Treat 151:235–238CrossRefPubMed
11.
go back to reference Arnold KM, Opdenaker LM, Flynn D, Sims-Mourtada J (2015) Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer. Cancer Growth Metastas 8:1–13 Arnold KM, Opdenaker LM, Flynn D, Sims-Mourtada J (2015) Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer. Cancer Growth Metastas 8:1–13
12.
go back to reference Ceelen W, Pattyn P, Mareel M (2014) Surgery, wound healing, and metastasis: recent insights and clinical implications. Crit Rev Oncol Hematol 89:16–26CrossRefPubMed Ceelen W, Pattyn P, Mareel M (2014) Surgery, wound healing, and metastasis: recent insights and clinical implications. Crit Rev Oncol Hematol 89:16–26CrossRefPubMed
13.
go back to reference Fitzal F, Sporn EP, Draxler W, Mittlbock M, Taucher S, Rudas M, Riedl O, Helbich TH, Jakesz R, Gnant M (2006) Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients. Breast Cancer Res Treat 97:9–15CrossRefPubMed Fitzal F, Sporn EP, Draxler W, Mittlbock M, Taucher S, Rudas M, Riedl O, Helbich TH, Jakesz R, Gnant M (2006) Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients. Breast Cancer Res Treat 97:9–15CrossRefPubMed
14.
go back to reference Chen AM, Haffty BG, Lee CH (2002) Local recurrence of breast cancer after breast conservation therapy in patients examined by means of stereotactic core-needle biopsy. Radiology 225:707–712CrossRefPubMed Chen AM, Haffty BG, Lee CH (2002) Local recurrence of breast cancer after breast conservation therapy in patients examined by means of stereotactic core-needle biopsy. Radiology 225:707–712CrossRefPubMed
15.
go back to reference King TA, Hayes DH, Cederbom GJ, Champaign JL, Smetherman DH, Farr GH, Bolton JS, Fuhrman GM (2001) Biopsy technique has no impact on local recurrence after breast-conserving therapy. Breast J 7:19–24CrossRefPubMed King TA, Hayes DH, Cederbom GJ, Champaign JL, Smetherman DH, Farr GH, Bolton JS, Fuhrman GM (2001) Biopsy technique has no impact on local recurrence after breast-conserving therapy. Breast J 7:19–24CrossRefPubMed
16.
go back to reference Hoorntje LE, Schipper ME, Kaya A, Verkooijen HM, Klinkenbijl JG, Borel Rinkes IH (2004) Tumour cell displacement after 14G breast biopsy. Eur J Surg Oncol 30:520–525CrossRefPubMed Hoorntje LE, Schipper ME, Kaya A, Verkooijen HM, Klinkenbijl JG, Borel Rinkes IH (2004) Tumour cell displacement after 14G breast biopsy. Eur J Surg Oncol 30:520–525CrossRefPubMed
17.
go back to reference Thurfjell MG, Jansson T, Nordgren H, Bergh J, Lindgren A, Thurfjell E (2000) Local breast cancer recurrence caused by mammographically guided punctures. Acta Radiol 41:435–440CrossRefPubMed Thurfjell MG, Jansson T, Nordgren H, Bergh J, Lindgren A, Thurfjell E (2000) Local breast cancer recurrence caused by mammographically guided punctures. Acta Radiol 41:435–440CrossRefPubMed
18.
go back to reference Chao C, Torosian MH, Boraas MC, Sigurdson ER, Hoffman JP, Eisenberg BL, Fowble B (2001) Local recurrence of breast cancer in the stereotactic core needle biopsy site: case reports and review of the literature. Breast J 7:124–127CrossRefPubMed Chao C, Torosian MH, Boraas MC, Sigurdson ER, Hoffman JP, Eisenberg BL, Fowble B (2001) Local recurrence of breast cancer in the stereotactic core needle biopsy site: case reports and review of the literature. Breast J 7:124–127CrossRefPubMed
19.
go back to reference Hobson J, Gummadidala P, Silverstrim B, Grier D, Bunn J, James T, Rincon M (2013) Acute inflammation induced by the biopsy of mouse mammary tumors promotes the development of metastasis. Breast Cancer Res Treat 139:391–401CrossRefPubMedPubMedCentral Hobson J, Gummadidala P, Silverstrim B, Grier D, Bunn J, James T, Rincon M (2013) Acute inflammation induced by the biopsy of mouse mammary tumors promotes the development of metastasis. Breast Cancer Res Treat 139:391–401CrossRefPubMedPubMedCentral
21.
go back to reference Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56:4625–4629PubMed Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56:4625–4629PubMed
22.
go back to reference Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605–612CrossRefPubMed Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605–612CrossRefPubMed
23.
go back to reference Ham M, Moon A (2013) Inflammatory and microenvironmental factors involved in breast cancer progression. Arch Pharmacal Res 36:1419–1431CrossRef Ham M, Moon A (2013) Inflammatory and microenvironmental factors involved in breast cancer progression. Arch Pharmacal Res 36:1419–1431CrossRef
24.
go back to reference Butowski N, Colman H, De Groot JF, Omuro AM, Nayak L, Wen PY, Cloughesy TF, Marimuthu A, Haidar S, Perry A et al (2015) Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study. Neuro-oncology 18(4):557–564CrossRefPubMed Butowski N, Colman H, De Groot JF, Omuro AM, Nayak L, Wen PY, Cloughesy TF, Marimuthu A, Haidar S, Perry A et al (2015) Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study. Neuro-oncology 18(4):557–564CrossRefPubMed
25.
go back to reference von Tresckow B, Morschhauser F, Ribrag V, Topp MS, Chien C, Seetharam S, Aquino R, Kotoulek S, de Boer CJ, Engert A (2015) An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R inhibitor, in patients with relapsed or refractory hodgkin lymphoma. Clin Cancer Res 21:1843–1850CrossRef von Tresckow B, Morschhauser F, Ribrag V, Topp MS, Chien C, Seetharam S, Aquino R, Kotoulek S, de Boer CJ, Engert A (2015) An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R inhibitor, in patients with relapsed or refractory hodgkin lymphoma. Clin Cancer Res 21:1843–1850CrossRef
26.
go back to reference Zhang YJ, Wei L, Li J, Zheng YQ, Li XR (2013) Status quo and development trend of breast biopsy technology. Gland Surg 2:15–24PubMedPubMedCentral Zhang YJ, Wei L, Li J, Zheng YQ, Li XR (2013) Status quo and development trend of breast biopsy technology. Gland Surg 2:15–24PubMedPubMedCentral
27.
go back to reference Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T, Widmann WD (2012) Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 19:217–224CrossRefPubMed Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T, Widmann WD (2012) Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 19:217–224CrossRefPubMed
28.
go back to reference Nozawa H, Chiu C, Hanahan D (2006) Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 103:12493–12498CrossRefPubMedPubMedCentral Nozawa H, Chiu C, Hanahan D (2006) Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 103:12493–12498CrossRefPubMedPubMedCentral
29.
go back to reference Bald T, Quast T, Landsberg J, Rogava M, Glodde N, Lopez-Ramos D, Kohlmeyer J, Riesenberg S, van den Boorn-Konijnenberg D, Homig-Holzel C et al (2014) Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 507:109–113CrossRefPubMed Bald T, Quast T, Landsberg J, Rogava M, Glodde N, Lopez-Ramos D, Kohlmeyer J, Riesenberg S, van den Boorn-Konijnenberg D, Homig-Holzel C et al (2014) Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 507:109–113CrossRefPubMed
30.
go back to reference Ravin KA, Loy M (2016) The eosinophil in infection. Clin Rev Allerg Immunol 50(2):214–227 Ravin KA, Loy M (2016) The eosinophil in infection. Clin Rev Allerg Immunol 50(2):214–227
31.
go back to reference Stone KD, Prussin C, Metcalfe DD (2010) IgE, mast cells, basophils, and eosinophils. J Allerg Clin Immunol 125:S73–S80CrossRef Stone KD, Prussin C, Metcalfe DD (2010) IgE, mast cells, basophils, and eosinophils. J Allerg Clin Immunol 125:S73–S80CrossRef
33.
go back to reference Amini RM, Aaltonen K, Nevanlinna H, Carvalho R, Salonen L, Heikkila P, Blomqvist C (2007) Mast cells and eosinophils in invasive breast carcinoma. BMC Cancer 7:165CrossRefPubMedPubMedCentral Amini RM, Aaltonen K, Nevanlinna H, Carvalho R, Salonen L, Heikkila P, Blomqvist C (2007) Mast cells and eosinophils in invasive breast carcinoma. BMC Cancer 7:165CrossRefPubMedPubMedCentral
34.
go back to reference Dethlefsen C, Hojfeldt G, Hojman P (2013) The role of intratumoral and systemic IL-6 in breast cancer. Breast Cancer Res Treat 138:657–664CrossRefPubMed Dethlefsen C, Hojfeldt G, Hojman P (2013) The role of intratumoral and systemic IL-6 in breast cancer. Breast Cancer Res Treat 138:657–664CrossRefPubMed
35.
go back to reference Tawara K, Oxford JT, Jorcyk CL (2011) Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies. Cancer Manag Res 3:177–189PubMedPubMedCentral Tawara K, Oxford JT, Jorcyk CL (2011) Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies. Cancer Manag Res 3:177–189PubMedPubMedCentral
36.
go back to reference Conze D, Weiss L, Regen PS, Bhushan A, Weaver D, Johnson P, Rincon M (2001) Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells. Cancer Res 61:8851–8858PubMed Conze D, Weiss L, Regen PS, Bhushan A, Weaver D, Johnson P, Rincon M (2001) Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells. Cancer Res 61:8851–8858PubMed
Metadata
Title
Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation
Authors
Gabriela Szalayova
Aleksandra Ogrodnik
Brianna Spencer
Jacqueline Wade
Janice Bunn
Abiy Ambaye
Ted James
Mercedes Rincon
Publication date
01-06-2016
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2016
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-016-3839-3

Other articles of this Issue 3/2016

Breast Cancer Research and Treatment 3/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine